Beth Gilmour

ORCID: 0000-0003-4416-5969
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Tuberculosis Research and Epidemiology
  • Infectious Diseases and Tuberculosis
  • Child Nutrition and Water Access
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Global Maternal and Child Health
  • Pneumonia and Respiratory Infections
  • Parasites and Host Interactions
  • Mycobacterium research and diagnosis
  • Parasite Biology and Host Interactions
  • Data-Driven Disease Surveillance
  • Epilepsy research and treatment
  • Adolescent Sexual and Reproductive Health
  • HIV, Drug Use, Sexual Risk
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Zoonotic diseases and public health
  • COVID-19 Clinical Research Studies
  • Health disparities and outcomes
  • Immune responses and vaccinations
  • Global Health and Epidemiology
  • Climate Change and Health Impacts
  • HIV/AIDS Research and Interventions
  • Psychosomatic Disorders and Their Treatments
  • HIV/AIDS Impact and Responses

Curtin University
2021-2025

The Kids Research Institute Australia
2023-2025

Abstract Objectives Globally, China has the third highest number of tuberculosis (TB) cases despite high rates (85.6%) effective treatment coverage. Identifying risk factors associated with unsuccessful outcomes is an important component maximising efficacy TB control programmes. Methods Retrospective cohort study to evaluate 306,860 drug‐susceptible patients who underwent in Hunan Province, between 2013 and 2018. Univariable multivariable logistic regression models were used identify...

10.1111/tmi.13720 article EN cc-by Tropical Medicine & International Health 2022-01-11

Abstract Background Tuberculosis (TB) continues to be a major public health challenge in China. Understanding TB management delays within the context of China’s unique ethnic diversity may value tackling disease. This study sought evaluate impact minority status on diagnosis and treatment delays. Methods retrospective cohort was conducted patients diagnosed with Hunan Province, China between 2013 2018. Diagnosis delay defined as time interval onset symptoms date diagnosis. Treatment...

10.1186/s12879-022-07072-4 article EN cc-by BMC Infectious Diseases 2022-01-26

Abstract Background Soil transmitted helminth (STH) infections are estimated to impact 24% of the world’s population and responsible for chronic debilitating morbidity. Disadvantaged communities among worst affected further marginalized as infection prevalence fuels poverty cycle. Ambitious targets have been set eliminate STH infections, but accurate epidemiological data will be required inform appropriate interventions. This paper details protocol an analysis that aims produce spatial...

10.1186/s13643-024-02469-5 article EN cc-by Systematic Reviews 2024-02-06

Tuberculosis (TB) is the leading infectious cause of death globally. Several preventive measures are employed to prevent TB, yet there a paucity evidence on effectiveness these interventions. Therefore, this study aimed identify most effective interventions for reducing TB incidence.A systematic search was undertaken across five relevant databases including PubMed, SCOPUS, Web Science, Cochrane Central Register Controlled Trials, and ClinicalTrials.gov from inception February 22, 2023....

10.1016/j.eclinm.2023.102209 article EN cc-by EClinicalMedicine 2023-09-09

While bacille-calmette-guerin (BCG) vaccination is one of the recommended strategies for preventing tuberculosis (TB), its coverage low in several countries, including Ethiopia. This study investigated spatial co-distribution and drivers TB prevalence BCG ecological was conducted using data from a national survey Ethiopian demographic health (EDHS) to map prevalence. A Bayesian geostatistical model built identify distribution coverage. defined as number children who received vaccine divided...

10.1038/s41598-024-68549-7 article EN cc-by-nc-nd Scientific Reports 2024-12-30

Despite impacting mankind since ancient times, tuberculosis (TB) persists as the leading cause of death from an infectious disease. TB can remain latent and further research is required to understand activation risk risks vs. benefits treating infection. Drug resistance poses escalating threat active disease achieving cure. Recent advances in molecular epidemiological techniques facilitate early diagnosis, drug susceptibility testing opportunity better transmission dynamics. Research ongoing...

10.3389/ftubr.2024.1487518 article EN cc-by Frontiers in Tuberculosis 2024-12-24
Coming Soon ...